MicroPort MedBot (2252) Receives Approval for H Share Full Circulation

Bulletin Express
02/13

Shanghai MicroPort MedBot (Group) Co., Ltd. (Stock Code: 2252) has announced that on 13 February 2026 it received listing approval from The Stock Exchange of Hong Kong Limited for the conversion and listing of 5.99 million unlisted shares, representing about 0.58% of the company’s total issued share capital.

These shares are to be converted into H shares held by two participating shareholders. After the conversion, the total number of unlisted shares will decline to approximately 0.06% of the company’s total issued share capital, while H shares will rise to 99.94%. The total number of shares remains at 1,031.33 million.

The company will complete the relevant procedures and disclose further progress of the H share full circulation process as required. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10